首页> 中文期刊> 《药学学报(英文版)》 >Cytotoxic and antibacterial polyketide-indole hybrids synthesized from indole-3-carbinol by Daldinia eschscholzii

Cytotoxic and antibacterial polyketide-indole hybrids synthesized from indole-3-carbinol by Daldinia eschscholzii

         

摘要

Two skeletally undescribed polyketide-indole hybrids (PIHs),named indolchromins A and B,were generated from indole-3-carbinol (I3C) in the fungal culture (Daldinia eschscholzii).The indoichromin structures were elucidated mainly by their 1D and 2D NMR spectra with the former confirmed by the single-crystal X-ray crystallographic analysis.Each indolchromin alkaloid was chirally separated into four isomers,whose absolute configurations were assigned by comparing the recorded circular dichroism (CD) spectra with the electronic CD (ECD) curves computed for all optional stereoisomers.Furthermore,the indolchromin construction pathways in fungal culture were clarified through enzyme inhibition,precursor feeding experiment,and energy calculation.The cascade reactions,including decarboxylative Claisen condensation catalyzed by 8-amino-7-oxononanoate synthase (AONS),C(sp3)-H activation,double bond migration,and Michael addition,all undergone compatibly during the fungal cultivation.In an MIC range of 1.3-8.6 μmol/L,(2S,4R)-and (2R,4S)-indolchromin A and (2R,4S)-indolchromin B are inhibitory against Clostridium perfringens,Clostridium difficile,Veillonella sp.,Bacteroides fragilis,and Streptococcus pyogenes.(2R,4S)-Indolchromin A and (2S,4S)-indolchromin B were cytotoxic against the human breast cancer cell line MDA-MB-231 with IC50 values of 27.9 and 131.2 nmol/L,respectively,with the former additionally active against another human breast cancer cell line MCF-7 (IC50 94.4 nmol/L).

著录项

  • 来源
    《药学学报(英文版)》 |2019年第2期|369-380|共12页
  • 作者单位

    State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing 210046, China;

    State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210023 China;

    School of Pharmacy, Nanjing Medical University, Nanjing 210029, China;

    State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210023 China;

    Department of Clinical Laboratory, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China;

    State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing 210046, China;

    State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210023 China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号